ArticleJACC. Case reports2025
Successful Thromboaspiration in STEMI Due to Extensive Coronary Thrombosis of Unclear Cause.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNew devices that allow continuous mechanical thromboaspiration are available. CASE SUMMARY: A 59-year-old woman with no relevant medical history presented with anterior ST-segment elevation myocardial infarction and extensive thrombosis, with complete occlusion in the middle-third left anterior descending artery. Adequate establishment of coronary flow could not be achieved after multiple attempts with plain-old balloon angioplasty. Continuous mechanical thromboaspiration was then performed with a CAT RX aspiration system, obtaining normalization of distal coronary flow. DISCUSSION: The routine use of thromboaspiration does not constitute the standard of endovascular management, but with a high thrombotic burden refractory to angioplasty, thromboaspiration represented the greatest clinical benefit, and after successful intervention, the patient's progress was satisfactory. TAKE-HOME MESSAGES: Patients with high myocardium mass at risk and notable thrombotic burden in whom conventional endovascular management has been ineffective may represent a subgroup of patients who can benefit the most from mechanical thromboaspiration. New devices that allow continuous thromboaspiration have been shown to be safe and effective, achieving very low or no residual thrombotic burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.